Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in PD Patients
ChiCTR2600118624Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Feb 2026
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amino acid peritoneal dialysis solution in end-stage kidney disease (ESKD), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Serum albumin at 6 months. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
amino acid peritoneal dialysis solution
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2600118624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118624.